TY - JOUR
T1 - A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients
AU - Rosatelli, Maria Cristina
AU - Meloni, Alessandra
AU - Meloni, Antonella
AU - Devoto, Marcella
AU - Cao, Antonio
AU - Scott, Hamish S.
AU - Peterson, Part
AU - Heino, Maarit
AU - Krohn, Kai J.E.
AU - Nagamine, Kentaro
AU - Kudoh, Jun
AU - Shimizu, Nobuyoshi
AU - Antonarakis, Stylianos E.
N1 - Funding Information:
Acknowledgements We thank the families with APECED for their collaboration and donation of samples. We thank Marie-Pierre Pa-pasavvas and Colette Rossier for outstanding technical assistance. M.C.R. and A.C. were supported by grants from the Assessorato Ig-iene e Sanità Regione Sardegna (L.R. No11, 30 April 1990), A.M. by a grant from the National Research Council, and M.D. by an NHGRI grant (HG00008). S.E.A. was supported by grants from the Swiss FNRS 31-40500.94 and the European Union/OFES CT93-0015 and funds from the University and Cantonal Hospital of Geneva. K.K. was supported by EU Biomed2 programme CA grant (BNH4-CT95-0729) and by grants from Tampere University Hospital Medical Research Fund. N.S. was supported by Funds for Human Genome Sequencing Project from the Japan Science and Technology Corporation (JST); Grants in Aid for Scientific Research on Priority Areas and Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan; and the Fund for “Research for the Future” Program from the Japan Society for the Promotion of Science (JSPS).
PY - 1998
Y1 - 1998
N2 - Autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy (APECED; also called APS-1,) is a rare autosomal recessive disorder that is more frequent in certain isolated populations. It is characterized by two of the three major clinical symptoms that may be present: Addison's disease, and/or hypoparathyroidism and/or chronic mucocutaneous candidiasis. We have recently identified the gene for APECED, which we termed AIRE (for autoimmune regulator). AIRE is expressed in thymus, lymph nodes and fetal liver, and encodes a protein with two putative zinc fingers and other motifs suggestive of a transcriptional regulator. Seven mutations have been described to date, including R257X, the predominant Finnish and northern Italian APECED allele, which has also been observed in other patients of diverse origin on different haplotypes. A 13-bp deletion (1094-1106del) has also been observed in several patients of different geo-ethnic origin. The other described mutations appear to be rare. We present mutational analyses of the AIRE gene in ten Sardinian APECED families and show that there is a mutation, R139X, associated with one predominant haplotype unique to the Sardinian patients (18/20 independent alleles). The carrier frequency of R139X in Sardinia is 1.7%, giving an estimated population frequency of APECED of 1/14,400. Using linkage disequilibrium data, the estimated age of the R139X mutation is between 20 and 25 generations. A previously described 13-bp deletion was also observed on an allele of one patient. The identification of a single common Sardinian APECED mutation will facilitate its genetic diagnosis. Given the carrier frequency of R139X in the Sardinian population, AIRE may be implicated in the pathogenesis of other autoimmune diseases in the Sardinian population, particularly those affecting the endocrine system.
AB - Autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy (APECED; also called APS-1,) is a rare autosomal recessive disorder that is more frequent in certain isolated populations. It is characterized by two of the three major clinical symptoms that may be present: Addison's disease, and/or hypoparathyroidism and/or chronic mucocutaneous candidiasis. We have recently identified the gene for APECED, which we termed AIRE (for autoimmune regulator). AIRE is expressed in thymus, lymph nodes and fetal liver, and encodes a protein with two putative zinc fingers and other motifs suggestive of a transcriptional regulator. Seven mutations have been described to date, including R257X, the predominant Finnish and northern Italian APECED allele, which has also been observed in other patients of diverse origin on different haplotypes. A 13-bp deletion (1094-1106del) has also been observed in several patients of different geo-ethnic origin. The other described mutations appear to be rare. We present mutational analyses of the AIRE gene in ten Sardinian APECED families and show that there is a mutation, R139X, associated with one predominant haplotype unique to the Sardinian patients (18/20 independent alleles). The carrier frequency of R139X in Sardinia is 1.7%, giving an estimated population frequency of APECED of 1/14,400. Using linkage disequilibrium data, the estimated age of the R139X mutation is between 20 and 25 generations. A previously described 13-bp deletion was also observed on an allele of one patient. The identification of a single common Sardinian APECED mutation will facilitate its genetic diagnosis. Given the carrier frequency of R139X in the Sardinian population, AIRE may be implicated in the pathogenesis of other autoimmune diseases in the Sardinian population, particularly those affecting the endocrine system.
UR - http://www.scopus.com/inward/record.url?scp=0031753977&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031753977&partnerID=8YFLogxK
U2 - 10.1007/s004390050846
DO - 10.1007/s004390050846
M3 - Article
C2 - 9856486
AN - SCOPUS:0031753977
SN - 0340-6717
VL - 103
SP - 428
EP - 434
JO - Human genetics
JF - Human genetics
IS - 4
ER -